SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
Sponsors
Chinese Academy of Medical Sciences
Conditions
SARS-CoV-2 InfectionSARS-CoV2 Infection
Phase 3
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above
NCT05163652
Start: 2021-12-18End: 2022-10-30Target: 432Updated: 2022-03-02
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above
NCT05164731
Start: 2021-12-16End: 2022-10-30Target: 880Updated: 2022-02-16
Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)
NCT05216484
Start: 2022-02-18End: 2022-12-30Target: 480Updated: 2022-05-23